Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC28A1 | O00337 | 1/20 | 0.48 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.48 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.48 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.48 |
| ▸ | DPAGT1 | Q9H3H5 | 2/20 | 0.47 |
| ▸ | P2RY2 | P41231 | 11/20 | 0.44 |
| ▸ | P2RY4 | P51582 | 4/20 | 0.44 |
| ▸ | P2RY14 | Q15391 | 1/20 | 0.44 |
| ▸ | P2RY6 | Q15077 | 6/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30256182 | 1.00 | SLC28A1 (0.48) | SLC28A1SLC28A2SLC29A1SLC28A3DPAGT1 | |
| SCHEMBL19401549 | 1.00 | SLC28A1 (0.48) | SLC28A1SLC28A2SLC29A1SLC28A3DPAGT1 | |
| SCHEMBL22763979 | 1.00 | SLC28A1 (0.48) | SLC28A1SLC28A2SLC29A1SLC28A3DPAGT1 | |
| SCHEMBL30256620 | 1.00 | SLC28A1 (0.48) | SLC28A1SLC28A2SLC29A1SLC28A3DPAGT1 | |
| SCHEMBL25752513 | 0.93 | SLC28A1 (0.50) | SLC28A1SLC28A2SLC29A1SLC28A3DPAGT1 | |
| SCHEMBL31278694 | 0.89 | SLC28A1 (0.47) | SLC28A1SLC28A2SLC29A1SLC28A3DPAGT1 | |
| SCHEMBL19397204 | 0.89 | SLC28A1 (0.43) | SLC28A1SLC28A2SLC29A1SLC28A3DPAGT1 | |
| SCHEMBL19397206 | 0.89 | SLC28A1 (0.43) | SLC28A1SLC28A2SLC29A1SLC28A3DPAGT1 | |
| SCHEMBL25739842 | 0.89 | SLC28A1 (0.43) | SLC28A1SLC28A2SLC29A1SLC28A3DPAGT1 | |
| SCHEMBL25739843 | 0.89 | SLC28A1 (0.43) | SLC28A1SLC28A2SLC29A1SLC28A3DPAGT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170275626-A1 | MODIFIED DOUBLE-STRANDED RNA AGENTS | BANK OF AMERICA, N.A. | 2017-09-28 | — | — | US | disclosed |